This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
P&G (PG) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Company News for Apr 22, 2024
by Zacks Equity Research
Companies in The News Are: PG,AXP,RFFITB
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
Key Insights from Corporate Earnings
by Zacks Equity Research
Key Insights from Corporate Earnings
Procter & Gamble (PG) Q3 Earnings Top Estimates, Sales Miss
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results gain from sales growth across operating segments, improved organic sales and margin expansion, offset by higher SG&A expenses.
Pre-Markets Point to a Lower Week; P&G, AmEx, Fifth Third Beat
by Mark Vickery
Market indices have stemmed the tide from triple-digit losses early this morning, but are still in the red.
P&G (PG) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for P&G (PG) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Procter & Gamble (PG) Q3 Earnings Beat Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 7.04% and 1.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Markets Mixed as Q1 Earnings, Powell Control News Headlines
by Mark Vickery
Wednesday morning brings us more Q1 earnings reports, including from Abbott Labs (ABT) and U.S. Bancorp (USB).
Unlocking Q3 Potential of P&G (PG): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for P&G (PG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Will Strategies Help Procter & Gamble (PG) Beat on Q3 Earnings?
by Zacks Equity Research
Procter & Gamble (PG) is progressing well with its pricing actions, business investments, and productivity and cost-saving plans. These are likely to have supported its Q3 performance.
Procter & Gamble (PG) Stock Moves -0.33%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $155.33 in the latest trading session, marking a -0.33% move from the prior day.
Procter & Gamble (PG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $155.84, marking a -0.89% move from the previous day.
Will P&G (PG) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
P&G (PG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Wall Street Analysts See P&G (PG) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Here is What to Know Beyond Why Procter & Gamble Company (The) (PG) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Procter & Gamble (PG) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Procter & Gamble (PG) stood at $156.10, denoting a +0.42% change from the preceding trading day.
Pricing Strategy Aids Procter & Gamble (PG): Stock to Gain
by Zacks Equity Research
Procter & Gamble (PG) witnesses strong business momentum, driven by underlying strength in brands and appropriate strategies, which boosts organic sales growth.
5 Blue-Chip Stocks to Buy Despite Dow's Recent Meltdown
by Nalak Das
We have narrowed our search to five Dow stocks that have strong potential for 2024. These stocks are: AXP, TRV, PG, IBM, CAT.
Procter & Gamble (PG) Stock Moves -0.45%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) concluded the recent trading session at $155.45, signifying a -0.45% move from its prior day's close.
Xenia Hotels & Resorts and THOR have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Xenia Hotels & Resorts and THOR have been highlighted as Zacks Bull and Bear of the Day.
The Zacks Analyst Blog Highlights Berkshire Hathaway, Procter & Gamble, Adobe, Advanced Micro Devices and AstraZeneca
by Zacks Equity Research
Berkshire Hathaway, Procter & Gamble, Adobe, Advanced Micro Devices and AstraZeneca are included in this Analyst Blog.